140 likes | 151 Views
This presentation by Dr. Jun Ishigooka explores the scientific aspects of placebo use in the treatment of major depression. It discusses the law of initial value, different placebo responses in a single disorder, and indicators for melancholia. The talk also delves into the main effect and alternative interaction models, as well as the use of surrogate endpoints and rating scales for symptoms.
E N D
How Scientific Is placebo Use? Jun Ishigooka, MD, PhD Department of Psychiatry, Kitasato University School of Medicine Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Scientific Issues in Placebo Use • “the Law of Initial Value” • Different Placebo Responses in a Single Disorder Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Scientific Issues in Placebo Use • “the Law of Initial Value” Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Conventional • Main Effect Model b. Alternative Interaction Model (Fisher S et al, 1965) Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Panic Disorder (1) (Uhlenhuth EH et al, 1997) Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Panic Disorder (2) (Uhlenhuth EH et al, 1997) Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Panic Disorder (3) (Uhlenhuth EH et al, 1997) Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Rating Scales for Symptoms ---Manner of Drug / Placebo Response??? ---Surrogate Endpoint Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Scientific Issues in Placebo 2. Different Placebo Responses in a Single Disorder Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Placebo Responses in Antidepressants Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Indicators for Melancholia Jun Ishigooka_the 3rd Kitasato-Harvard Symposium
Major Depression Jun Ishigooka_the 3rd Kitasato-Harvard Symposium